Manning Paul B 4
4 · Candel Therapeutics, Inc. · Filed Dec 18, 2024
Insider Transaction Report
Form 4
Manning Paul B
Director
Transactions
- Purchase
Common Stock
2024-12-16$6.00/sh+750,000$4,500,000→ 1,303,752 total(indirect: By LLC) - Purchase
Common Stock
2024-12-16$6.00/sh+500,000$3,000,000→ 1,142,406 total(indirect: By Trust)
Holdings
- 1,681,000
Common Stock
Footnotes (3)
- [F1]The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F2]The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F3]Includes shares held jointly with spouse.